Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy

OBJECTIVE: Perampanel is an oral anti‐seizure medication, which is approved in Japan for focal‐onset seizures, with/without focal to bilateral tonic–clonic seizures, as monotherapy/adjunctive therapy in patients aged 4 years and older. Treatment for generalized tonic–clonic seizures as adjunctive th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanaya, Ryosuke, Kubota, Yuichi, Mizobuchi, Masahiro, Iida, Koji, Ono, Tomonori, Motooka, Hiromichi, Nakano, Naoki, Fujimoto, Ayataka, Iwasaki, Masaki, Fukuda, Masafumi, Kondo, Akihiko, Uruno, Katsuhisa, Yamamuro, Shintaro, Yamaguchi, Kohei, Onishi, Kisaki, Ngo, Leock Y, Inoue, Yushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690696/
https://www.ncbi.nlm.nih.gov/pubmed/37547978
http://dx.doi.org/10.1002/epi4.12804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690696/
https://www.ncbi.nlm.nih.gov/pubmed/37547978
http://dx.doi.org/10.1002/epi4.12804

Ejemplares similares